Complete Filing Data
JBS N.V. reported Profit Loss of $2.23 billion for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean JBS N.V. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Profit Loss | $2.23B | $1.97B | -$131.7M |
| Comprehensive Income | $3.16B | -$391.3M | $609.2M |
| Profit Loss From Operating Activities | $4.16B | $4.38B | $1.08B |
| Profit Loss Before Tax | $2.62B | $2.71B | -$259.7M |
| Profit Loss Attributable To Owners Of Parent | $2.02B | $1.77B | -$198.9M |
| Profit Loss Attributable To Noncontrolling Interests | $205.5M | $200.7M | $67.1M |
| Other Fair Value Adjustments Through Other Comprehensive Income | -$25.0K | -$2.8M | -$13.1M |
| Other Comprehensive Income Net Of Tax Gains Losses On Remeasurements Of Defined Benefit Plans | $865.0K | $18.3M | $11.2M |
| Other Comprehensive Income | $925.4M | -$2.36B | $740.9M |
| Income Tax Relating To Remeasurements Of Defined Benefit Plans Of Other Comprehensive Income | $169.0K | $4.6M | $2.8M |
| Income Tax Expense Continuing Operations | $390.5M | $743.4M | -$128.0M |
| Gross Profit | $11.30B | $11.59B | $7.97B |
| General And Administrative Expense | $2.19B | $2.28B | $2.32B |
| Gains Losses On Financial Assets Measured At Fair Value Through Other Comprehensive Income Net Of Tax | -$8.4M | $796.0K | $6.9M |
| Gains Losses On Deferred Income Tax Onloss Cash Flow Hedges | $1.4M | -$202.0K | -$1.7M |
| Cost Of Sales | $74.88B | $65.59B | $64.95B |
| Comprehensive Income Attributable To Owners Of Parent | $3.09B | -$756.4M | $567.3M |
| Comprehensive Income Attributable To Noncontrolling Interests | $63.3M | $365.0M | $41.8M |
| Other Fair Value Adjustment Through Other Comprehensive Income | -$2.8M | ||
| Income Taxes Paid Refund Classified As Operating Activities | $809.0M | $348.7M | $70.9M |
| Adjustments For Reconcile Profit Loss | -$6.93B | -$6.89B | -$3.55B |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Rightofuse Assets | $1.61B | $1.60B | $1.71B | $1.61B |
| Property Plant And Equipment | $13.65B | $11.78B | $12.92B | $11.92B |
| Noncurrent Biological Assets | $611.8M | $518.2M | $531.5M | $502.0M |
| Investment Accounted For Using Equity Method | $171.6M | $38.3M | $56.6M | $56.5M |
| Intangible Assets Other Than Goodwill | $1.83B | $1.80B | $1.99B | $1.98B |
| Current Biological Assets | $1.83B | $1.61B | $1.71B | $1.86B |
| Cash And Cash Equivalents | $4.57B | $5.61B | $4.57B | $2.53B |
| Increase Decrease Through Transfers And Other Changes Equity | $37.0K | -$137.0K | ||
| Gains Losses On Cash Flow Hedges Net Of Tax | $594.0K | $5.1M | ||
| Deferred Tax Expense Income | -$59.7M | -$127.1M | -$197.5M | |
| Dividend Payables | $1.50B | $358.6M | ||
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $2.10B | $1.48B | $1.50B | |
| Purchase Of Other Longterm Assets Classified As Investing Activities | $7.1M | $10.6M | $9.0M | |
| Noncash Additions To Right Of Use Assets And Lease Liabilities | $404.1M | $505.0M | $483.7M | |
| Margin Cash Classified As Financing Activities | -$16.6M | $20.1M | -$26.6M | |
| Gains Losses On Hedges Of Net Investments In Foreign Operations Net Of Tax | -$421.9M | $179.6M | ||
| Gains Losses On Fair Value Adjustment Biological Assets | $19.1M | $158.6M | -$85.0M | |
| Deferred Tax Assets | $547.0M | $651.2M | ||
| Changes In Operating Assets And Liabilities Classified As Operating Activities | $2.88B | $1.37B | $74.2M | |
| Cash Flows From Used In Operations | $4.05B | $5.52B | $3.48B | |
| Cash Flows From Used In Operating Activities | $2.93B | $4.23B | $2.38B | |
| Cash Flows From Used In Investing Activities | -$2.31B | -$1.42B | -$1.41B | |
| Cash Flows From Used In Financing Activities | -$1.77B | -$1.41B | $1.02B | |
| Adjustments For Share Of Profit Of Equityaccounted Investees | -$16.9M | -$2.9M | -$9.5M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | $73.2M | $47.2M | $72.0M |
| Proceeds From Borrowings Classified As Financing Activities | $10.09B | $2.98B | $9.04B |
| Payments Of Loans And Financing Classified As Financing Activities | $8.75B | $2.99B | $7.09B |
| Payments Of Lease Liabilities Classified As Financing Activities | $432.5M | $417.8M | $428.7M |
| Increase Decrease In Taxes Paid In Installments | $55.7M | $61.0M | $48.1M |
| Increase Decrease In Cash And Cash Equivalents | -$1.05B | $1.04B | $2.04B |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | $102.8M | -$352.9M | $50.6M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Diluted Earnings Loss Per Share | $1.89 | $1.65 | $-0.19 |
| Basic Earnings Loss Per Share | $1.89 | $1.65 | $-0.19 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Selling Expense | $4.99B | $4.83B | $4.59B |
| Other Income | $111.9M | $84.5M | $148.6M |
| Other Expense By Nature | $75.5M | $189.3M | $122.2M |
| Operating Expense | $7.14B | $7.21B | $6.88B |
| Increase Decrease Through Sharebased Payment Transactions | $15.8M | $6.9M | |
| Gains Losses On Exchange Differences On Translation Net Of Tax | $931.7M | -$2.37B | $740.6M |
| Gains Losses On Changes In Effect Of Limiting Net Defined Benefit Asset To Asset Ceiling Excluding Interest Income Or Expense Net Of Tax Defined Benefit Plans | $13.6M | $8.3M | |
| Finance Income Cost | -$1.56B | -$1.67B | -$1.35B |
| Finance Income | $565.2M | $719.4M | $584.2M |
| Finance Costs | $2.12B | $2.39B | $1.94B |
| Current Tax Expense Income | $450.2M | $870.5M | $69.5M |
| Dividends Paid | $4.3M | $6.3M | |
| Related Party Transactions Classified As Investing Activities | -$53.9M | $21.2M | $1.0M |
| Reclassification Adjustments On Exchange Differences On Translation Net Of Tax | $1.95B | -$561.0M | |
| Issued Capital | $35.1M | $13.18B | |
| Interest Received Classified As Operating Activities | $188.4M | $192.2M | $187.4M |
| Interest Paid Classified As Operating Activities | $1.30B | $1.49B | $1.29B |
| Increase Decrease Through Distribution Of Proposed Interim Dividends | $1.18B | $448.0M | |
| Dividends Received Classified As Investing Activities | $7.3M | $10.7M | $12.6M |
| Dividends Paid To Noncontrolling Interests | $356.2M | $4.3M | $5.9M |
| Derivative Instruments Receivedsettled Classified As Financing Activities | -$86.8M | -$232.0M | -$12.7M |
| Capitalized Interest | $35.0M | $31.7M | $68.2M |
| Adjustments For Sharebased Payments | $28.9M | $15.8M | $6.9M |
| Adjustments For Provisions | $189.4M | $47.2M | $106.1M |
Most recent annual filing with the SEC: March 25, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.